A study conducted by Donnem et al. identified that miR-155, an altered angiogenesis-related microRNAs in NSCLC, has a significant correlation with FGF2, which indicates the potential significance of FGF signaling in tumor invasions in NSCLC [107]. This evidence concerns the gene FGF2 and non-small cell lung carcinoma.